PRIME ELEMENTS of Ordinary Matter, Dark Matter & Dark Energy ...
Getting to the heart of genomic dark matter
-
Upload
jelani-dixon -
Category
Documents
-
view
48 -
download
5
description
Transcript of Getting to the heart of genomic dark matter
Getting to the heart of genomic dark matter
Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart specific long non-
coding RNAs.
Samir Ounzain, Ph.D
Pedrazzini LabDepartment of Medicine
Experimental Cardiology UnitUniversity of Lausanne Medical School
Switzerland
@ispiyou@CardiolncRNA
Ounzain S, Micheletti R, Beckmann T, Schroen B, Alexanian M, Pezzuto I, Crippa S, Nemir M, Sarre A, Johnson R, Dauvillier J, Burdet F, Ibberson M, Guigó R, Xenarios I, Heymans S, Pedrazzini T. Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel
heart-specific long non-coding RNAs. Eur Heart J. 2014 Apr 30.
Response to biomechanical stress in the adult heart
Compensated FailingNormal
Biomechanical StressMyocardial InfarctionHypertension
Cardiomyocyte hypertrophy
Gradual loss of cardiomyocytes
Fibroblast proliferation
Massive loss of myocytes
Fibrosis
Electro-mechanicalRemodeling
Mobilization of immature cardiomyocytesand cardiac stem cells
Regeneration
What we have: Fewer myocytes
More fibrosis
What we want: More myocytes
Less fibrosis
Cardiac gene regulatory networks
Functions in the heart are poorly characterized
Hu, W et al (2012) Regulation of mammalian cell differentiation by long non-coding RNAs. EMBO Reports
Long non-coding RNAs – Characteristics and mechanisms of action
Typically (A) >200bp (B) lack coding potential (C) PolyA(+) (D) Pol2 transcribed (E) multi-exonicHighly tissue/context specific – Thousands likely exist
Characterizing the mouse long non-coding (lncRNA) transcriptome
Humanortholog identification
1110 lncRNAsMouse model
Human heart disease
Myocardialinfarction
14 d.
Borderzone
Poly A(+) RNA-Sequencing
ab initio reconstruction
Association with specific chromatin state
transitions
Heart specificity
mR
NA
s
UC
SC
ln
cRN
As
Nov
el ln
cRN
As
Correlation with cardiac physiology
Functional roles as Enhancer derived ncRNAs
p300
H3K4me1
H3K4me3
H3K27Ac
H3K27me3
Mouse enhancer
LVLA
RA
RV
UCSC mRNA UCSC lncRNA
Novel lncRNA
8.7% (1521)5.6%
85.7%
Novel lncRNAs exhibit significant cardiac specific expression
All transcriptsH
eart
sp
ecif
icit
yH
eart
sp
ecif
icit
yH
eart
sp
ecif
icit
y
15075 UC
SC
mR
NA
s988 U
CS
C ln
cRN
As
1521 No
vel lncR
NA
s
Hea
rt
ShamHeart
MIHeart
17 non cardiac tissues
Cufflinks
Pred
ictio
ns
+
-
+
-
+
-
+
-
Heart
Testis
Kidney
Liver
Str
and
sp
ecif
ic
tran
scri
pti
on
Lung
Stomach
PhastConsVertebrates
+
-
+
-
Novlnc6
Novel lncRNAs exhibit significant cell and sub-cellular specificity
Novlnc333
Novlnc174
Novlnc95
Novlnc86
Novlnc44
Novlnc90
Novlnc103
Novlnc96
Novlnc49
Novlnc11
Novlnc15
Novlnc32
Novlnc76
Novlnc61
Novlnc6
Novlnc35
Novlnc23
CMFibr.
0 0.05 0.10 0.15-0.05-0.10-0.15
Novlnc11
Novlnc95
Novlnc49
Novlnc76
Novlnc86
Novlnc44
Novlnc96
Novlnc90
Novlnc15
Novlnc6
Novlnc35
Novlnc333
Novlnc61
Novlnc174
Novlnc103
Novlnc32
Novlnc23
CMFibr.
0 2 4-2-4
Delta Fold Change Nuc. Cyto.Cyto/Nuc Ratio
Novel lncRNAs are highly correlated with cardiac physiological traits
LV m
ass
/ BW
LV m
ass
IVR
TS
A M
I tra
ceS
A L
V a
rea;
dL
A M
I tra
ceL
A L
V a
rea;
d
LVID
; s
LV v
olu
me;
sLV
ID;
dLV
vo
lum
e; d
LVP
W;
dLV
PW
; s
EF
FS
IVS
; s
IVS
; d
Bo
dy
wei
gh
tH
eart
rat
e
LA
LV
are
a; s
Echocardiography derived traits
1.
2.
3.
4.
No
vel l
ncR
NA
s
Correlation
2.0
1.5
1.0
0.5
0.25 0.50 0.75 1.00
Den
sity
EF2.0
1.5
1.0
0.5
0.25 0.50 0.75 1.00
Correlation
Den
sity
MI Trace
UCSC lncRNAs
Novel lncRNAs0 0.5 1.0-1.0 -0.5
Correlation
Heart specific transcripts (%)
EF
0.25 0.50 0.75 1.00
1
2
3
4
5
Den
sit
y
Correlation
Cluster 1
Cluster 2
Cluster 3
Cluster 4
Novlnc35
mhy7
Novlnc6Novlnc15
Novlnc76
Novlnc61
Novlnc103
Novlnc174
Novlnc23
Novlnc333
Novlnc32
Novlnc49
Novlnc11
Novlnc95
Novlnc90
Novlnc86
Novlnc96
Novlnc44
col1actgfnppatgfb2
LV m
ass
/ B
W
LA M
I tr
ace
SA
MI
trac
e
LV m
ass
SA
LV
are
a; d
LA L
V a
rea;
d
LA L
V a
rea;
s
LVID
; s
LV v
olum
e; s
LVID
; d
LV v
olum
e; d
Hea
rt r
ate
Bod
y w
eigh
t
IVS
; s
LVP
W;
s
EF
FS
LVP
W;
d
IVS
; d
0 0.5-0.5
Border Zone
70
50
30
10
0-1-2-3
Novlnc6
EF
(%
)
R=0.785
70
50
30
10
0-1-2-3-4
Novlnc15
R=0.811
70
50
30
10
0-1-2-3 1
Novlnc95
R=0.785
Fold change over Sham
70
50
30
10
10 21
Novlnc174
R=-0.538
Fold change over Sham
70
50
30
10
321-1 0
Myh7
R=-0.426
70
50
30
10
210-2 -1
Col1a
R=-0.484
70
50
30
10
210-1
Nppa
R=-0.788E
F (
%)
Novel lncRNAs Cardiac markers
Novel lncRNAs are highly correlated with cardiac physiological traits
Myocardialinfarction
Borderzone
Novel lncRNAs are associated with cardiac specific active enhancers
H3K4me3+H3K27me3 bivalent/poised promoterH3K4me3+H3K27ac active/initiating promoterH3K4me3 initiating promoterH3K27me3+H3K4me1 poised developmental enhancerH3K4me1 poised enhancerH3K27ac+H3K4me1 active enhancer H3K27me3 Polycomb repressed
ENCODE Data SetsChIP-Seq data sets from 5 mouse whole tissues
Novel lncRNAs are associated with cardiac specific active enhancers
H3K
4me1
H3K
4me3
H3K
27A
cH
3K27
me3
PhastConsVertebrates
Heart
Kidney
Liver
Spleen
Testis
Cufflinks
Pred
ictio
ns
Heart
Kidney
Liver
Spleen
Testis
Heart
Kidney
Liver
Spleen
Testis
Heart
Kidney
Liver
Spleen
Testis
Novlnc6
Enhancer
Inferring functions for novel lncRNAs based on chromatin state transitions
Embryonicstem cells
Mesodermalprecursors
Cardiacprecursors
Cardiomyocytes
Exp
ress
ion
Genes
Lineage-specific gene expression
Stages of differentiation
x y z x y z x y z x y z
Based on Wamstad JA et al. 2012. Cell 151: 206Paige SL et al. 2012. Cell 151: 221
Embryonicstem cells
Mesodermalprecursors
Cardiacprecursors
Cardiomyocytes
Exp
ress
ion
En
rich
men
tE
nri
chm
ent
En
rich
men
tE
nri
chm
ent
H3K4me3
H3K27me3
H3K4me1
H3K27Ac
Genes
Lineage-specific gene expression
Functional inference
Stages of differentiation
x y z x y z x y z x y z
Ch
rom
atin
e st
ate
tran
siti
on
Based on Wamstad JA et al. 2012. Cell 151: 206Paige SL et al. 2012. Cell 151: 221
Inferring functions for novel lncRNAs based on chromatin state transitions
1st pattern
2nd pattern
3rd pattern
Cluster 1(gene x, plus other geneswith similar pattern)
34 Patterns / Clusters
Cluster 2(gene y, plus other geneswith similar pattern)
Cluster 3(gene z, plus other geneswith similar pattern)
Wamstad JA et al. 2012. Cell 151: 206
Inferred function based on top GO
terms
Cluster
1 House keeping
2 House keeping
3 House keeping
4 Cellular homeostasis
5 Pluripotency, Metabolic process
6 Metabolic process, Transport
7 Cellular homeostasis, Matrix
8 Channel activity, Signaling
9 Development
10 Vascular homeostasis
11 Pluripotency, Development
12 Renal homeostasis
13 Catabolic process
14 Metabolic process
15 Enzymatic activity
16 Inflammatory response
17 Metabolic process
18 Inflammatory response
19 Inflammatory response
20 Contraction, Heart development
21 G-protein coupled receptors
22 G-protein coupled receptors
23 Contraction, Heart development
24 Contraction, Heart development
25 Contraction, Heart development
26 Contraction, Heart development
27 Contraction, Heart development
28 G-protein coupled receptors
29 House keeping
30 Contraction
31 Transcription, Translation
32 Mitochondrial activity
33 Translation
34 Translation
Novel lncRNAs are associated with cardiac specific chromatin state clusters
1
3
18
25 2623 24
28
USCS mRNAs
20
27
2
Novel lncRNAs
1
3
18
28
26
24
23
20
27
25
2
- 5.70
- 4.00
- 2.00
0.00
2.00
4.00
7.25
Down Unchanged Up
1
3
23
24
28
18
Pearsonresidual
20
27
2
2526
Definition of 34 clusters corresponding to 34 groupsof genes that are functionally related
E.g.: Cluster 1, 2, 3: House keeping function Cluster 18: Immune/Inflammatory response Cluster 20, 23-27: Cardiac development, muscle contraction Cluster 28: Calcium homeostasis, GPCR signaling
Wamstad JA et al. 2012. Cell 151: 206
Sham vs. MI
Cluster-associated novel lncRNAs are enriched in –up/-down regulated lncRNAs
Candidate cardiac enhancer derived lncRNA – Novlnc6
p300
H3K4me1
H3K4me3
H3K27Ac
H3K27me3
PhastConsVertebrates
Mouse enhancer
LVLA
RA
RV
Novlnc6 Nkx2.5
Scrambled
Novlnc6 Gapmer 1
Bmp10 Gata4 Tbx20 Myh6 Myh7
Fol
d ch
ange
ove
r S
cram
ble
Novlnc6 Gapmer 2
** *** * * *
Remote ZoneBorder Zone
d1 d7
*
d1 d7
* *
Fol
d ch
ange
over
Sha
m d
1Novlnc6
d1 d7
*
Nppa
Fol
d ch
ange
over
Sha
m d
1
*
d1 d7
*Col1a
d1 d7
*
EF
*
%
Novel lncRNAsChromatin State Clusters
1
3
18
28
26
24
23
20
27
252
Novlnc6
Bmp10
Cardiomyocytes
Novlnc6Gapmers
70
50
30
10
210-1
Nppa70
50
30
10
0-1-2-3
Novlnc6
EF
(%
)
R=0.785
R=-0.788
Nkx2.5
Novlnc6 is modulated in human heart disease
Hs Novlnc6
p < 0.001
Nkx2.5 Nppa Col1a
p < 0.05 p < 0.001 p < 0.001
p < 0.01 p < 0.01
TransMapped Human Orthologs
PhastConsVertebrates
Mammalian Basewise PhyloP
Hs Novlnc6
p < 0.001
EF
p < 0.001
PW thickness
Dilated cardiomyopathy
Aortic stenosis
1100 human orthologs identified
Summary Identified 1500 novel lncRNAs in the infarcted mouse heart
Novel lncRNAs are heart specific
Novel lncRNAs are highly correlated with physiological traits
Novel lncRNAs are enriched at heart specific active enhancers
Inferred novel lncRNA functions based on chromatin states
Conserved novel lncRNAs are modulated in human disease
Unique characteristics of novel lncRNAs render them ideal tissue specific therapeutic targets and biomarker candidates
Rudi MichelettiTal BeckmannMichael AlexanianIole PezzutoStefania CrippaMohamed NemirPedrazzini Lab
@ispiyou@CardiolncRNA
Jerome DauvillierFrederic BurdetMark IbbersonIoannis Xenarios
Rory JohnsonRoderic Guigo
Blanche SchroenStephane Heymans
Alexandre Sarre Keith Harshman